Regulatory Update: Supervised and Home Based Exercise With Ergonomic Training in Textile Workers (NCT07408401) Not Yet Recruiting

By Dr. Hatem Rabeh · Published February 13, 2026 · Updated March 16, 2026

Meta description: A regulatory update on a textile worker study evaluating supervised and home based exercise with ergonomic training, sponsored by Okan University and listed on ClinicalTrials.gov. On February 15, 2026 a textile worker study registered as NCT07408401 is listed as not yet recruiting. The study tests an integrated exercise program with ergonomic training for workers in the textile sector, with supervision and a home based component. The record notes the interventions as supervised exercise and home exercise and lists Okan University as sponsor. The listing suggests a potential medical device relevance without providing device specifics in the material provided. Readers should track the ClinicalTrials.gov entry for updates.

What changed in regard to the textile worker program?

The entry shows a structured approach to workplace health. The interventions are listed as supervised exercise and a home based exercise component. This combination aims to address musculoskeletal stress common in textile settings. The absence of a detailed device description in the provided material means the study’s current regulatory status centers on trial design and sponsor oversight rather than device performance data. The not yet recruiting status indicates the trial has not yet started recruitment. The sponsor is Okan University and the ClinicalTrials.gov listing provides a public reference for the record. For regulatory professionals the key fact is that the record identifies an intended program rather than a marketed device at this stage, with possible device relevance implied by the search term used in the listing link.

Who is affected by this study?

The target population comprises textile workers who may experience ergonomic strain and musculoskeletal discomfort. Implementing an ergonomic training component alongside exercise can influence safety and performance in the workplace. The current record does not provide participant results, adverse event data, or outcomes, and status remains not yet recruiting. Stakeholders outside the trial arena should monitor for updates on recruitment progress and any regulatory or safety disclosures connected to the study.

What is the regulatory context for such studies?

In a regulatory frame the entry demonstrates the existence of a defined intended purpose and safety considerations associated with a study that may involve a device referenced in the listing. The MDR framework expects a clear statement of intended use and a description of risk controls. The available material does not describe specific device features, performance claims or clinical outcomes. As such the current communications focus on trial design, sponsor identity, and the not yet recruiting status rather than device approval or market clearance.

What are the safety considerations and oversight?

Safety considerations are implied by the trial design and by the not yet recruiting status. Providers and employers may consider baseline risk assessment for musculoskeletal disorders and ensure informed consent once recruitment begins. The sponsor and the coordinating centers will be responsible for monitoring adverse events, data integrity, and adherence to good clinical practice if recruitment proceeds. Until results are available no conclusions about efficacy or safety can be stated.